CONCLUSIONS : Clinicians are exhorted to pay close attention when initiating levofloxacin therapy in patients taking medications with epileptogenic properties that are CYP1A2 substrates .
O O O O O O O O O O O B-ChemicalEntity O O B-OrganismTaxon O O O O O O O B-GeneOrGeneProduct O O